These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15081461)

  • 1. Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy.
    Reinhard W; Ten Cate FJ; Scholten M; De Laat LE; Vos J
    Am J Cardiol; 2004 Apr; 93(8):1064-6. PubMed ID: 15081461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
    J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of biventricular pacing on left ventricular outflow tract pressure gradient in a patient with hypertrophic cardiomyopathy and normal interventricular conduction.
    Komsuoglu B; Vural A; Agacdiken A; Ural D
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):207-9. PubMed ID: 16533259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
    Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
    Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
    J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol septal ablation complicated by complete heart block and permanent pacemaker failure.
    Valettas N; Rho R; Beshai J; Lloyd CT; Ross HM; Kocovic D; Herrmann HC
    Catheter Cardiovasc Interv; 2003 Feb; 58(2):189-93. PubMed ID: 12552542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.
    Chang SM; Nagueh SF; Spencer WH; Lakkis NM
    J Am Coll Cardiol; 2003 Jul; 42(2):296-300. PubMed ID: 12875767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures.
    Nielsen CD; Killip D; Spencer WH
    Clin Cardiol; 2003 Jun; 26(6):275-9. PubMed ID: 12839045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic rounds series II: hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy.
    Kern MJ; Rajjoub H; Bach R
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):221-8. PubMed ID: 10376511
    [No Abstract]   [Full Text] [Related]  

  • 12. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
    Kar S; Makkar R
    Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy.
    Gadler F; Linde C; Daubert C; McKenna W; Meisel E; Aliot E; Chojnowska L; Guize L; Gras D; Jeanrenaud X; Kappenberger L
    Eur Heart J; 1999 Jul; 20(14):1044-50. PubMed ID: 10381856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    van Dockum WG; Beek AM; ten Cate FJ; ten Berg JM; Bondarenko O; Götte MJ; Twisk JW; Hofman MB; Visser CA; van Rossum AC
    Circulation; 2005 May; 111(19):2503-8. PubMed ID: 15867172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pacing for heart block after septal reduction therapy.
    Okreglicki AM
    Am J Cardiol; 2004 Nov; 94(9):1224. PubMed ID: 15518634
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS
    Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
    Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
    Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.